Our research teams focus on cancer, immunology and autoimmune diseases (including diabetes), neuroscience and neurodegenerative diseases (including Alzheimer’s disease), life-cycle biology (including development, stem cells, aging and regenerative medicine), the microbiome and computational biology.
Multiple JAX research centers unite experts around critical research areas including cancer, aging, Alzheimer’s disease, addiction biology, precision genetics, rare and orphan diseases, vision and computational biology.
JAX has more than 60 faculty with independent research programs, and more than 400 JAX staff members hold Ph.D., M.D., D.V.M. or D.Sc. advanced degrees.
In 2022, JAX researchers were supported by $65.3 million in peer-reviewed research funding (annual direct costs).
Our researchers have made significant contributions to medical progress, including bone marrow and organ transplants, stem cell therapies and in vitro fertilization.
We offer comprehensive educational programs for scientists throughout their careers, from high school students and teachers, to researchers at all experience levels, and for clinical providers interested in incorporating genetics and genomics into their practices.
Over 2,400 organizations in 68 countries rely on over 13,000 strains of genetically-specialized JAX® Mice and research services in a wide range of therapeutic areas.